PARSIPPANY, N.J.--(BUSINESS WIRE)--Jan. 3, 2006--The Medicines Company (NASDAQ: MDCO) is scheduled to present at the JP Morgan Healthcare Conference on Tuesday, January 10th, at 4:30pm Pacific Time. Clive Meanwell, Chairman and Chief Executive Officer, is expected to discuss company operations, Angiomax(R) (bivalirudin) marketing, and development updates for Angiomax, clevidipine and cangrelor.
